"Now I’ve got to the point where I think we can get almost complete control of cardiovascular disease, heart attacks and strokes by the proper use of vitamin C and lysine. It can prevent cardiovascular disease and even cure it." Linus Pauling Interview, Journal of Orthomolecular Medicine, 1994.
12 Years of Proof
Tower's experience demonstrates that replacement dosages of ascorbic acid (vitamin C), lysine and the other nutrients in the amounts recommended by Linus Pauling rapidly reverse the symptoms of heart disease in most people including angina, atherosclerosis, high blood pressure and high cholesterol, and thereby lower the risk of heart attack and stroke.
The science behind Tower's products and the effectiveness of the Pauling therapy are explained and corroborated by 12 years of positive customer testimonials and are now documented in the following resources:
Practicing Medicine Without a License? The Story of the Linus Pauling Therapy for Heart Disease (which outlines Pauling's recommendations, Tower's 12-year Pauling therapy history, and successful Pauling therapy case histories) by Owen Fonorow and Sally Snyder Jewell
Stop America's #1 Killer! (which cites more than 650 supporting scientific studies) by Thomas Levy, M.D., J.D.
Heart Disease - Unified Theory of Cause and Cure DVD lecture on the subject made by Linus Pauling himself.
Know Your Own Lp(a) Score
The Lipoprotein (a) test is seldom ordered by physicians in routine cholesterol testing and most continue to remain ignorant about the importance of this test. Nearly half of all people who suffer heart attacks have normal cholesterol panels but elevated Lp(a). You can obtain your own Lp(a) measurement by asking your doctor to order an Lp(a) test at your next office visit. Be sure to ask whether the Lp(a) score will be measured (true value) or computed (estimated value). If the test is not available through your doctor or if he knows conclusively that the laboratory performing the test simply computes Lp(a) values, you can also ask your doctor to order a VAP Cholesterol Test from Atherotech, which is a very reliable lipoprotein (a) test for determining true heart attack risk. Still Have
Still Have Questions About the Pauling Therapy?
"Every person in America — every person in the world — should be made aware of this discovery. We cannot imagine a valid reason for performing another coronary artery bypass graft surgery, angioplasty, or stent placement . . . without first trying Pauling’s therapy."
~Owen Fonorow, Sally
Jewell, Practicing
Medicine Without a License? The Story of the Linus Pauling Therapy for Heart Disease © 2008 
A Disease or a Symptom?
According to Linus Pauling and others, the condition that doctors euphemistically label as "heart disease" is not a disease at all. Rather, it is a symptom of an enzyme missing in humans that is needed in order to make ascorbic acid (vitamin C) in the body - the enzyme gulonolactone oxidase, or GLO. Without high levels of ascorbic acid, the human body cannot manufacture the vast amounts of collagen necessary for the maintenance of vascular health, and the coronary arteries that are closest to the heart and subject to the greatest degree of mechanical stress suffer the scorbutic (scurvy) effect.
Tower products are not a frank "cure" because they do not replace the body's missing enzyme (the true disease). Rather, Tower products replace the nutrient - vitamin C - that other species WITH the enzyme that do not get blockages are able to make for themselves.
| ||||
Plaque forms on the coronary artery when the artery is deficient in collagen from a chronic ascorbic acid (vitamin C) deficiency, a condition known as scurvy.
Arterial scurvy is reversed only with intake of the levels of vitamin C recommended by Pauling to make collagen, while the reinforcing plaque is eliminated with the amino acid component of Pauling's therapy, a/k/a Lp(a) binding inhibitors.
CORONARY
ARTERY DISEASE
The Problem - The U. S. RDA Causes Arterial Scurvy
The miniscule amount of vitamin C in the U. S. RDA of 60 to 75 mg will prevent death from the vitamin C deficiency disease scurvy but is not nearly sufficient for the body to make enough collagen to maintain the strength and integrity of its entire cardiovascular system and specifically the coronary arteries. The amount of daily vitamin C necessary to treat latent or chronic scurvy, also known as human atherosclerosis, is nearly 100 times higher than the RDA. No human who consumes the RDA of 75 mg or less is immune to heart disease. In fact, Pauling's research concluded that daily intake of no less than 3,000 mg is required for adequate collagen synthesis and protection from heart disease.
The Invention - Lp(a) Binding Inhibitors
In 1989, after the discoveries of the Lp(a) cholesterol molecule (circa 1964) and its lysine binding sites (circa 1987) and the fact that this cholesterol variant is responsible for the plaques which form in response to arterial scurvy via Lp(a)'s attraction to the exposed lysine in the damaged arteries, Linus Pauling and his associate Matthias Rath formulated A Unified Theory of Human Cardiovascular Disease which was published in the Journal of Orthomolecular Medicine in 1994 and invented what is now referred to as the "Pauling therapy" (vitamin C/lysine and the other nutrients) treatment for heart disease.
Vitamin C and lysine in large amounts (and smaller amounts of proline and other nutrients) become Lp(a) cholesterol binding inhibitors that restore vascular health and are patented to destroy atherosclerotic plaques. Pauling's experiments proved that "simply administering the proper nutrients, in the proper combination, at the proper dosage could eradicate heart disease."
Pauling's findings were published in the Proceedings of the National Academy of Science (1990, Vol 87, pp 6204-6207). Pauling was awarded a patent on his formula, Patent #5,278,189, Jan. 11, 1994, Prevention and Treatment of Occlusive Cardiovascular Disease With Ascorbate and Substances that Inhibit the Binding of Lipoprotein (a).
The News That Should Have Changed the World
Pauling himself indicated during a 1994 Interview when questioned about the significance of these findings:
THE PAULING THERAPY
IS IT A "CURE" FOR HEART DISEASE?
The Pauling Therapy
Disclaimer: The Food and Drug Administration (FDA) has not evaluated any statements on this Website. Tower Laboratories Corporation does not make health claims for its products. Tower Laboratories products are not intended to diagnose, treat or cure any disease. Tower is not responsible for independent third parties who may otherwise represent the efficacy of its products. These individuals are not Tower's agents and do not have permission to do so. Unsatisfactory products sold in the USA may be returned for a full refund within 60 days of the original ship date.
Made in the U.S.A. • Copyright © 2008 • All Rights Reserved.
Tower Laboratories Corporation • 3432 N. Bruce Street, Suite 3 • North Las Vegas, NV 89030-8023 • (702) 876-5805
Home | Products | Online Store | The Pauling Therapy | Linus Pauling | Testimonials | Policies | Contact
In Pauling's last private telephone interview with reporter Peter Barry Chowka conducted on April 9, 1994, he expressed his dismay that this theory of heart disease wasn't formulated and the disease eradicated decades earlier, stating:
". . . I have trouble understanding why somebody interested in heart disease didn't think of it 20 or 30 years ago when it was accepted by cardiologists that the primary cause of atherosclerosis and heart disease is a lesion in the wall of an artery in a region of stress. So I asked myself two or three years ago, 'Why should there be a lesion in the wall of the artery?' Animals don't have these lesions in regions of stress. Well, you have the lesions because arteries are weak. Why are they weak? Ordinarily, animals' arteries are strengthened by the deposit of collagen. And you can't make collagen without using up vitamin C. Humans don't get enough vitamin C, so their arteries are weak. And then a lesion forms, followed by the other stages of developing heart disease. THEREFORE, DEFICIENT INTAKE OF VITAMIN C IS A PRIMARY CAUSE OF CARDIOVASCULAR DISEASE."
